首页> 外文期刊>International Orthopaedics >Survival and functional outcome of the Birmingham hip resurfacing system in patients aged 65 and older at up to ten years of follow-up
【24h】

Survival and functional outcome of the Birmingham hip resurfacing system in patients aged 65 and older at up to ten years of follow-up

机译:伯明翰髋关节表面置换系统在长达10年的随访中对65岁及65岁以上患者的生存和功能结局

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose: Limited evidence exists regarding the outcomes of hip resurfacing in elderly patients. The primary study aims were to determine the survival and functional outcome following Birmingham Hip Resurfacing (BHR) in patients ≥65 years at up to ten years of follow-up. Secondary aims were to explore factors affecting survival and functional outcome. Methods: Between 1997 and 2012, data were prospectively collected on 180 BHR (162 patients; mean age 69.2 years; 62% male) implanted by one designing surgeon. Mean follow-up was six (range one to 14.4) years with no loss to follow-up. Outcomes of interest were implant survival, functional outcome [Oxford Hip Score (OHS)] and radiological evidence of implant failure. Results: Three hips were revised, giving an overall cumulative survival of 96.4% [95% confidence interval (CI) 90.3-100] at ten years. Survival of 111 male BHR was 98.9% (95% CI 94.8-100) at ten years (one revision) compared with 91.9% (95% CI 77.0-100) in 69 female BHR (two revisions). Survival was affected by age (p=0.014) and femoral head size (p=0.024) but not by gender (p=0.079). Median pre-operative OHS was 50.0% [interquartile range (IQR) 37.5-68.8], improving to 4.4% (IQR 0-10.4) postoperatively. Men had significantly better postoperative OHSs compared with women (median male OHS 2.1% versus 6.3% female OHS; p=0.021). Conclusions: Good survival and functional outcomes were achieved with the BHR at ten years in men and women ≥65 years. Despite registry findings to the contrary, age alone should not be a contraindication for hip resurfacing in centres with expertise in this procedure.
机译:目的:关于老年患者髋关节表面置换结果的证据有限。主要研究目的是确定≥65岁的患者在伯明翰髋关节表面置换术(BHR)后的生存期和功能结局,长达十年的随访时间。次要目标是探索影响生存和功能结局的因素。方法:从1997年至2012年,前瞻性收集了由一名设计外科医生植入的180例BHR(162例患者,平均年龄69.2岁; 62%男性)的数据。平均随访时间为6年(范围从1到14.4),无随访损失。感兴趣的结果是植入物存活,功能结局[牛津髋关节评分(OHS)]和植入物失败的放射学证据。结果:改良了三只髋关节,十年后整体累积生存率为96.4%[95%置信区间(CI)90.3-100]。 111位男性BHR在十年(一次修订)中的生存率为98.9%(95%CI 94.8-100),而69位女性BHR(两次修订)为91.9%(95%CI 77.0-100)。存活率受年龄(p = 0.014)和股骨头大小(p = 0.024)的影响,而不受性别(p = 0.079)的影响。术前OHS的中位数为50.0%[四分位间距(IQR)37.5-68.8],术后提高到4.4%(IQR 0-10.4)。男性术后OHS明显高于女性(男性OHS中位数为2.1%,女性OHS为6.3%; p = 0.021)。结论:≥65岁的男性和女性在10岁时BHR可实现良好的生存和功能结局。尽管注册表发现有相反的结论,但年龄本身不应成为具有该手术专业知识的中心进行髋关节表面置换的禁忌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号